Entity
  • Texcell

    Created in 2003
  • Social networks

    4,230
  • Activities

  • Technologies

  • Entity types

  • Location

    1 Rue Pierre Fontaine 5, 91000 Évry-Courcouronnes, France

    Évry-Courcouronnes

    France

  • Employees

    Scale: 51-200

    Estimated: 113

  • SIREN

    444906978
  • Engaged corporates

    7
    0 7
  • Added in Motherbase

    3 years, 2 months ago
Description
  • Value proposition

    Expert in viral safety since 1987.

    Texcell is a dedicated partner for biotechnology and pharmaceutical companies since more than 2 decades.
    Thanks to an unique combination of expertise in Virology and Immunology, we can provide a full support to your product development from the proof of concept to clinical studies and GMP manufacturing.
    Our state-of the Art facilities are located in France, Germany and in the US where we use most recent technologies to efficiently perform a wide range of assays
    What do we provide ?

    A specialized analytical lab for your preclinical and clinical studies, including:
    - Cell based assays/potency assays during development
    - Immunogenicity, TK/PK, ADA and neutralizing Antibody Testing
    - Immunotoxicology studies
    - Sample pre analytics: serum/plasma isolation, PBMC isolation & storage
    - Biobanking
    - Read-outs: ELISA, ECLIA, Flow cytometry, ELISpot, HAI, proliferation...

    Texcell Viral Safety lab:
    Expertise in biosafety of biological and pharmaceutical products.
    - Virus/TSE Validation - Viral Clearance study - 25 model viruses available - spiking in L2 and L3 labs...
    - Viral safety testing - a complete range of tests (NGS, in vitro, in vivo, TEM, Q-PCR...) to characterize cell banks and ensure microbiological safety (viruses, mycoplasma, etc...).
    - Cell and Gene therapy (ATMPs) and Biodistribution/biodissemination - experience with adenovirus, retrovirus, lentivirus...
    - Virucidal Norm and cleaning validation
    - Standard Toxicology and Medical Device Biocompatibility studies (ISO 10993)

    Texcell GMP cell bank facility:
    Expertise in handling and growing more than one hundred mammalian cell lines.
    - Production of RCB, MCB and WCB in GMP
    - Modern class B and class C cell culture room
    - Dedicated class B room to fill automatically cells in vials
    - Culture of adherent and suspension cell line with single use disposable
    - Viral safety control of cell banks performed directly in-house

    For more information visit www.texcell.com.

    Viral Safety, Bioanalysis, GLP, GMP, GCLP, Medical Device, Biosafety Testing, Viral Clearance, Safety Testing, Immunoprofiling, and Clinical trials

  • Original language

    Expert in viral safety since 1987.

    Texcell is a dedicated partner for biotechnology and pharmaceutical companies since more than 2 decades.
    Thanks to an unique combination of expertise in Virology and Immunology, we can provide a full support to your product development from the proof of concept to clinical studies and GMP manufacturing.
    Our state-of the Art facilities are located in France, Germany and in the US where we use most recent technologies to efficiently perform a wide range of assays
    What do we provide ?

    A specialized analytical lab for your preclinical and clinical studies, including:
    - Cell based assays/potency assays during development
    - Immunogenicity, TK/PK, ADA and neutralizing Antibody Testing
    - Immunotoxicology studies
    - Sample pre analytics: serum/plasma isolation, PBMC isolation & storage
    - Biobanking
    - Read-outs: ELISA, ECLIA, Flow cytometry, ELISpot, HAI, proliferation...

    Texcell Viral Safety lab:
    Expertise in biosafety of biological and pharmaceutical products.
    - Virus/TSE Validation - Viral Clearance study - 25 model viruses available - spiking in L2 and L3 labs...
    - Viral safety testing - a complete range of tests (NGS, in vitro, in vivo, TEM, Q-PCR...) to characterize cell banks and ensure microbiological safety (viruses, mycoplasma, etc...).
    - Cell and Gene therapy (ATMPs) and Biodistribution/biodissemination - experience with adenovirus, retrovirus, lentivirus...
    - Virucidal Norm and cleaning validation
    - Standard Toxicology and Medical Device Biocompatibility studies (ISO 10993)

    Texcell GMP cell bank facility:
    Expertise in handling and growing more than one hundred mammalian cell lines.
    - Production of RCB, MCB and WCB in GMP
    - Modern class B and class C cell culture room
    - Dedicated class B room to fill automatically cells in vials
    - Culture of adherent and suspension cell line with single use disposable
    - Viral safety control of cell banks performed directly in-house

    For more information visit www.texcell.com.

Corporate interactions BETA
Corporate TypeTweets Articles
Medicen Paris Region
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations
Other

22 Mar 2024


Amgen
Amgen
Biotechnology, Biotechnology Research
Amgen
Biotechnology, Biotechnology Research
Other

5 Mar 2024


Gilead Sciences
Gilead Sciences
Pharmaceutical, Biotechnology, Biotechnology Research
Gilead Sciences
Pharmaceutical, Biotechnology, Biotechnology Research
Other

5 Mar 2024


Bristol Myers Squibb
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Other

5 Mar 2024


Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Other

5 Mar 2024


Lyonbiopôle Auvergne-Rhône-Alpes
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

30 Nov 2022


Eurobiomed
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

26 Oct 2022


Similar entities
Loading...
Loading...
Social network dynamics